Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP

Torrent Pharmaceuticals Limited is expanding its voluntary recall from 2 lots of Losartan potassium tablets USP to a total of 10 lots, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Torrent is only recalling lots of losartan-containing products that contain N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA.

https://www.fda.gov/Safety/Recalls/ucm629261.htm

Source: Food and Drug Administration - January 3, 2019 Category: Food Science Source Type: news

More News: Cozaar | Food and Drug Administration (FDA) | Food Science | Losartan | Potassium